The Generation and Identity of Human Myeloid-Derived Suppressor Cells
Myeloid-derived suppressor cells (MDSCs) are cells of myeloid lineage with a potent immunosuppressive capacity. They are present in cancer patients as well as in patients with severe inflammatory conditions and infections. MDSCs exist as two main subtypes, the granulocytic (G-MDSCs) and the monocyti...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00109/full |
id |
doaj-ffc9bb3791d74e1c981399a015f6b294 |
---|---|
record_format |
Article |
spelling |
doaj-ffc9bb3791d74e1c981399a015f6b2942020-11-25T00:29:24ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-02-011010.3389/fonc.2020.00109514774The Generation and Identity of Human Myeloid-Derived Suppressor CellsCaroline Bergenfelz0Karin Leandersson1Department of Translational Medicine, Division of Experimental Infection Medicine, Lund University, Malmö, SwedenDepartment of Translational Medicine, Cancer Immunology, Lund University, Skåne University Hospital, Malmö, SwedenMyeloid-derived suppressor cells (MDSCs) are cells of myeloid lineage with a potent immunosuppressive capacity. They are present in cancer patients as well as in patients with severe inflammatory conditions and infections. MDSCs exist as two main subtypes, the granulocytic (G-MDSCs) and the monocytic (Mo-MDSCs) type, as defined by their surface phenotype and functions. While the functions of MDSCs have been investigated in depth, the origin of human MDSCs is less characterized and even controversial. In this review, we recapitulate theories on how MDSCs are generated in mice, and whether this knowledge is translatable into human MDSC biology, as well as on problems of defining MDSCs by their immature cell surface phenotype in relation to the plasticity of myeloid cells. Finally, the challenge of pharmacological targeting of MDSCs in the future is envisioned.https://www.frontiersin.org/article/10.3389/fonc.2020.00109/fullmyeloid-derived suppressor cellcancerinfectiondevelopmentdifferentiationmaturation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Caroline Bergenfelz Karin Leandersson |
spellingShingle |
Caroline Bergenfelz Karin Leandersson The Generation and Identity of Human Myeloid-Derived Suppressor Cells Frontiers in Oncology myeloid-derived suppressor cell cancer infection development differentiation maturation |
author_facet |
Caroline Bergenfelz Karin Leandersson |
author_sort |
Caroline Bergenfelz |
title |
The Generation and Identity of Human Myeloid-Derived Suppressor Cells |
title_short |
The Generation and Identity of Human Myeloid-Derived Suppressor Cells |
title_full |
The Generation and Identity of Human Myeloid-Derived Suppressor Cells |
title_fullStr |
The Generation and Identity of Human Myeloid-Derived Suppressor Cells |
title_full_unstemmed |
The Generation and Identity of Human Myeloid-Derived Suppressor Cells |
title_sort |
generation and identity of human myeloid-derived suppressor cells |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2020-02-01 |
description |
Myeloid-derived suppressor cells (MDSCs) are cells of myeloid lineage with a potent immunosuppressive capacity. They are present in cancer patients as well as in patients with severe inflammatory conditions and infections. MDSCs exist as two main subtypes, the granulocytic (G-MDSCs) and the monocytic (Mo-MDSCs) type, as defined by their surface phenotype and functions. While the functions of MDSCs have been investigated in depth, the origin of human MDSCs is less characterized and even controversial. In this review, we recapitulate theories on how MDSCs are generated in mice, and whether this knowledge is translatable into human MDSC biology, as well as on problems of defining MDSCs by their immature cell surface phenotype in relation to the plasticity of myeloid cells. Finally, the challenge of pharmacological targeting of MDSCs in the future is envisioned. |
topic |
myeloid-derived suppressor cell cancer infection development differentiation maturation |
url |
https://www.frontiersin.org/article/10.3389/fonc.2020.00109/full |
work_keys_str_mv |
AT carolinebergenfelz thegenerationandidentityofhumanmyeloidderivedsuppressorcells AT karinleandersson thegenerationandidentityofhumanmyeloidderivedsuppressorcells AT carolinebergenfelz generationandidentityofhumanmyeloidderivedsuppressorcells AT karinleandersson generationandidentityofhumanmyeloidderivedsuppressorcells |
_version_ |
1725331583334875136 |